The journal retracts the article “Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?” [1].
Following publication, concerns were brought to the attention of the Editorial Office regarding significant overlap with a previously published work [2] with a different authorship group and without appropriate citation.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and Editorial Board and confirmed the overlap, which included a number of identical sequences of references, abbreviations not commonly used in Molecules, as well as the lack of methodology that differentiates the current results from previous publications. This article is therefore retracted.
This retraction was approved by the Editor in Chief of the journal Molecules.
The authors disagree with this retraction.
References
- Agrawal, P.K.; Agrawal, C.; Blunden, G. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828. [Google Scholar] [CrossRef] [PubMed]
- Fuzimoto, A.D. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. J. Integr. Med. 2021, 19, 375–388. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).